Biobeat Technologies Ltd.
https://www.bio-beat.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Biobeat Technologies Ltd.
Arik Ishay Is Marching To The Biobeat Of His Own Drum
Biobeat defies the usual trend of start-ups seeking ever-growing sums of capital before either going public or being acquired. Its CEO, Arik Ben Ishay, believes the company can quickly become self-sufficient by tackling endemic problems.
Axogen, Dario Health, Biobeat, Immunexpress All Weigh In On 2022 And What Will Succeed In 2023
Medtech Insight was invited to ask questions at a roundtable event organized by Russo Partners to review the major medtech industry trends of 2022 and what to expect in 2023.
Recent Tech Transfer Deals, April 2012
START-UP ’s monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions—in in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical devices.
Medical Device Deals Update, March 2012
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
Company Information
- Industry
- Medical Devices
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice